
Love our content? Unlock even more!
Subscribe with your email to receive exclusive reports and expert research directly to your inbox every week.
(Your privacy is important to us; your information will be kept confidential and secure.)
Displaying 1-12 results out of 15
Sort by
Layout
In an interview with El Universo, one of Ecuador’s largest daily newspapers, John Walsh, WOLA’s Director for Drug Policy and…
Monday 12th June 2023 Dear Secretary General Guterres, We are writing to urge you to mark this year’s International Day…
A new study by the Research Consortium on Drugs and the Law (Colectivo de Estudios Drogas y Derecho, CEDD) analyzes…
The UN drug treaties expressly limit cannabis use to medical and scientific purposes, and cannabis is placed under the strictest…
Uruguay is the first country to legalize and regulate its domestic non-medical cannabis market. In light of this pioneering role,…
This commentary is a joint publication between the Costa Rican Association for Research and Intervention in Drugs (Asociación Costarricense para…
The people in the videos are featured because they represent the rarely revealed human side of the war on drugs.
Over three years after its passage, the final element of Uruguay’s historic cannabis law is set to be implemented on…
Across Latin America, the effects of disproportionate punishment for low-level, non-violent drug offenses are particularly severe for women. The following women were convicted and imprisoned for drug offenses in Colombia and Costa Rica. These are their stories.
This joint report analyzes the effects of drug policy in the Americas, including the militarization of law enforcement, the criminalization of consumption, the weakening of due process guarantees, mass incarceration, disproportionate penalties, and restrictions on access to health care.
In a paper produced for a Brookings Institution policy brief series, John Walsh and Geoff Ramsey review Uruguay’s pioneering policies that legalize and regulate every level of the market for cannabis.
Subscribe with your email to receive exclusive reports and expert research directly to your inbox every week.
(Your privacy is important to us; your information will be kept confidential and secure.)